Onal, C. Et Al. 2019. The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. FUTURE ONCOLOGY , vol.15, no.13 , 1469-1479.

Onal, C., Sedef, A. M., Kose, F., Oymak, E., Guler, O. C., Sumbul, A. T., ... AKSOY, S.(2019). The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. FUTURE ONCOLOGY , vol.15, no.13, 1469-1479.

Onal, Cem Et Al. "The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate," FUTURE ONCOLOGY , vol.15, no.13, 1469-1479, 2019

Onal, Cem Et Al. "The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate." FUTURE ONCOLOGY , vol.15, no.13, pp.1469-1479, 2019

Onal, C. Et Al. (2019) . "The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate." FUTURE ONCOLOGY , vol.15, no.13, pp.1469-1479.

@article{article, author={Cem Onal Et Al. }, title={The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate}, journal={FUTURE ONCOLOGY}, year=2019, pages={1469-1479} }